Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (101-110 of 192) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|February 21, 2022
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid TumorsRamón Lecumberri, Pedro Ruiz-Artacho, Inna Tzoran, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Journal of Clinical Medicine|July 9, 2022
The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-AnalysisCorinne Frere, Benjamin Crichi, Clémentine Wahl, et al.
Annals of the Rheumatic Diseases|August 30, 2011
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosusGabor G Illei, Ricard Cervera, Richard K Burt, et al.
Bone Marrow Transplantation|April 29, 2021
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosisRichard K Burt, Paolo A Muraro, Dominique Farge, et al.
Medicine|August 13, 2015
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous ThromboembolismDominique Farge, Javier Trujillo-Santos, Philippe Debourdeau, et al.
Science (New York, N.Y.)|May 15, 2010
Risks of immune system treatmentsRichard K Burt, Mario Abinun, Dominique Farge-Bancel, et al.
Haematologica|September 24, 2009
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesDominique Farge, Myriam Labopin, Alan Tyndall, et al.
Bulletin Du Cancer|January 19, 2023
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]Alexandre Thibault Jacques Maria, Arnaud Campidelli, Cristina Castilla-Llorente, et al.
Bone Marrow Transplantation|February 2, 2019
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Helen Jessop, Dominique Farge, Riccardo Saccardi, et al.
Pageof 20

Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|February 21, 2022
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid TumorsRamón Lecumberri, Pedro Ruiz-Artacho, Inna Tzoran, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Journal of Clinical Medicine|July 9, 2022
The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-AnalysisCorinne Frere, Benjamin Crichi, Clémentine Wahl, et al.
Annals of the Rheumatic Diseases|August 30, 2011
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosusGabor G Illei, Ricard Cervera, Richard K Burt, et al.
Bone Marrow Transplantation|April 29, 2021
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosisRichard K Burt, Paolo A Muraro, Dominique Farge, et al.
Medicine|August 13, 2015
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous ThromboembolismDominique Farge, Javier Trujillo-Santos, Philippe Debourdeau, et al.
Science (New York, N.Y.)|May 15, 2010
Risks of immune system treatmentsRichard K Burt, Mario Abinun, Dominique Farge-Bancel, et al.
Haematologica|September 24, 2009
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesDominique Farge, Myriam Labopin, Alan Tyndall, et al.
Bulletin Du Cancer|January 19, 2023
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]Alexandre Thibault Jacques Maria, Arnaud Campidelli, Cristina Castilla-Llorente, et al.
Bone Marrow Transplantation|February 2, 2019
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Helen Jessop, Dominique Farge, Riccardo Saccardi, et al.
Pageof 20